Success Stories: A Graduate Research Assistant in Biological Sciences Wins National Interest Waiver Approval without RFE, Thanks to Our Experts at NAILG

 

On March 11th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Biological Sciences (Approval Notice).


General Field: Biological Sciences

Position at the Time of Case Filing: Graduate Research Assistant

Country of Origin: Nepal

State of Residence at the Time of Filing: Georgia

Approval Notice Date: March 11th, 2022

Processing Time: 3 months, 22 days


Case Summary:

As a graduate research assistant from Nepal in the field of biological science, our NIW client’s proposed endeavor was to work on investigating the mechanisms of cardiometabolic issues. His goal was to establish improved treatment techniques for cardiovascular patients. It was evident that his work was not just nationally but globally pertinent due to the rising rates of cardiometabolic issues all over the world. This very data helped satisfy the first prong of the NIW requirement set by the USCIS. Our team further investigated his documentation to buttress the first prong test, and found the following:

  • Due to its clear national importance, his research has in fact been supported with funding from the National Institute of Diabetes and Digestive and Kidney Diseases, the American Diabetes Association, the National Institutes of Health, and the American River Nutrition, Inc.
  • Due to his knowledge and expertise, he has been regularly invited to conduct peer reviews for authoritative journals and organizations in the field for at least 5 reviews to date.
  • His research has resulted in 5 peer-reviewed journal articles (1 of them first-authored).
  • These publications have been cited a total of 39 times according to Google Scholar.
  • He has pursued research directly related to his proposed endeavor of investigating the underlying causes of cardiometabolic issues like cardiovascular disease, obesity, and diabetes through plant tissue culture and mouse model experimentation in order to establish improved treatment techniques for cardiovascular patients for 10 years.
  • We noted that his research into the mechanisms of cardiovascular conditions will continue to be circulated to others in the field through peer-reviewed journal articles and conference presentations.
  • He also plans to hold a position that is narrowly tailored to his unique skill set related to investigating the underlying causes of cardiometabolic issues.
  • Finally, his work is corroborated by 4 experts who furnished letters of recommendation for him.
We used all of this information to build a strong case for him finally winning him the approval in less than 4 months and that too without an RFE. We are glad to have had the opportunity to work with him and we are pleased to congratulate him on this victory. Our firm wishes him the very best in all future endeavors.